Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Epicore Bionetworks Inc. V.EBN

"Epicore Bionetworks Inc develops, manufactures and markets biotechnology products based on natural microbes and enzymes for the aquaculture, agriculture and municipal industries."

TSXV:EBN - Post Discussion

Epicore Bionetworks Inc. > Cargill eyes shrimp farming potential in Latin America
View:
Post by midard on Jun 01, 2017 10:06pm

Cargill eyes shrimp farming potential in Latin America

Shrimp production may see double digit growth for the next few years for India, Ecuador, Indonesia and Thailand, Cargill Group Director and VP Dan Burke told
Comment by rationalex on Jun 01, 2017 10:50pm
This is HUGE NEWS.   Cargill admitting to double-digit growth in Ecuador and Asia. Just a matter of time until EBN gets bought out. by them.   Hard to believe this is trading at 10 times earnings (after subtracting .22 in cash).
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities